Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis

计划入组 54 人 · 首次发布于 2021 年 11 月 10 日

Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors

计划入组 57 人 · 首次发布于 2025 年 7 月 25 日

A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors

计划入组 136 人 · 首次发布于 2007 年 1 月 17 日

BSI-118

BSI-082

BSI-715

TSI Group Co., Ltd.

Procaps Group

Luxembourg

ROCHET GROUP

France

Modular Medical Advances Tubeless Pivot Insulin Pump with October FDA Filing and Gamified Training Platform

Biosion Initiates Phase 1 Trial of BSI-082 Anti-SIRPα Antibody for Advanced Solid Tumors

LeukoStrat® CDx FLT3 Mutation Assay Receives EU Approval for AML Treatment Selection